Cargando…

Real-World Use of Clopidogrel and Ticagrelor in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: Patient Characteristics and Long-Term Outcomes

Background: Current guidelines recommend ticagrelor as the preferred P(2)Y(12) inhibitor on top of aspirin in patients after an acute coronary syndrome. Yet, the efficacy and safety of ticagrelor vs. clopidogrel in patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Side, Xu, Haobo, Huang, Sizhuang, Yuan, Jiansong, Yu, Mengyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724121/ https://www.ncbi.nlm.nih.gov/pubmed/34993242 http://dx.doi.org/10.3389/fcvm.2021.807494

Ejemplares similares

Impact of low triiodothyronine syndrome on long-term outcomes in patients with myocardial infarction with nonobstructive coronary arteries
por: Gao, Side, et al.
Publicado: (2021)

Hyperuricemia as a prognostic marker for long-term outcomes in patients with myocardial infarction with nonobstructive coronary arteries
por: Ma, Wenjian, et al.
Publicado: (2021)

Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
por: Gao, Side, et al.
Publicado: (2022)

Impact of prediabetes on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries
por: Gao, Side, et al.
Publicado: (2021)

Predictive value of the age, creatinine, and ejection fraction score in patients with myocardial infarction with nonobstructive coronary arteries
por: Gao, Side, et al.
Publicado: (2021)

Predictive Value of Free Triiodothyronine to Free Thyroxine Ratio in Euthyroid Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
por: Gao, Side, et al.
Publicado: (2021)

Sex-Specific Clinical Characteristics and Long-Term Outcomes in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
por: Gao, Side, et al.
Publicado: (2021)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry
por: Zhang, Yunnan, et al.
Publicado: (2022)

Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries
por: Lopez-Pais, Javier, et al.
Publicado: (2022)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
por: Vercellino, Matteo, et al.
Publicado: (2017)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Comparing the effectiveness and safety of dual antiplatelet with ticagrelor or clopidogrel in elderly Asian patients with acute myocardial infraction
por: Yeh, Jong-Shiuan, et al.
Publicado: (2023)

Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis
por: Olufade, Tope, et al.
Publicado: (2021)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study
por: Hee, Leia, et al.
Publicado: (2019)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)

Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Yao, Guangtao, et al.
Publicado: (2017)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
por: Samman, Karla N., et al.
Publicado: (2021)

A case report and literature review of myocardial infarction with nonobstructive coronary arteries (MINOCA) possibly due to acute coronary vasospasm induced by misoprostol
por: Hau, Nguyen Viet, et al.
Publicado: (2023)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
por: Lomakin, Nikita, et al.
Publicado: (2019)

Myocardial Infarction with Nonobstructive Coronary Arteries: A Diagnostic Challenge
por: Asamoah, Kofi Tekyi
Publicado: (2021)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: A Comprehensive Meta-Analysis
por: Sun, Mengyi, et al.
Publicado: (2022)

Real‐World Comparison of Ticagrelor and Clopidogrel: Rosetta Stone or Lost in Translation?
por: Bergmark, Brian A.
Publicado: (2020)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
por: Kim, Yuri, et al.
Publicado: (2023)

Risk of Thrombosis in Patients Presenting with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA)
por: Pasupathy, Sivabaskari, et al.
Publicado: (2018)

Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
por: Kumar, Viveka, et al.
Publicado: (2018)

Comparative Safety and Effectiveness of Ticagrelor versus Clopidogrel in Patients With Acute Coronary Syndrome: An On-Treatment Analysis From a Multicenter Registry
por: Almendro-Delia, Manuel, et al.
Publicado: (2022)

Low-dose and standard-dose ticagrelor compared with clopidogrel in patients with acute coronary syndromes: A cohort study from china
por: Peng, Wenxing, et al.
Publicado: (2022)

Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation
por: Marcano, Ana Lucrecia, et al.
Publicado: (2022)

Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease
por: Pelletier‐Galarneau, Matthieu, et al.
Publicado: (2017)

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions
por: Schmucker, Johannes, et al.
Publicado: (2019)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
por: Lee, Chih-Kuo, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation
por: Roh, Ji Woong, et al.
Publicado: (2022)

Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): It's Time to Face Reality!
por: Tamis‐Holland, Jacqueline E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e6qvau6p82j35qpin35e37qfl3